Reducing Risk in Small Molecule Development: Choosing the Right CDMO Partner

Terry Novak from Benuvia reviews the key strategies for reducing risk in small molecule development by prioritizing technical alignment and robust project management when selecting a contract development and manufacturing organization (CDMO). He explains how early collaboration is critical to accelerating timelines and ensuring a seamless transition from development to large-scale GMP manufacturing. He also covers emerging industry trends, including the strategic move toward reshoring and the increased demand for specialized expertise in niche markets.